vasoactive-intestinal-peptide and Paramyxoviridae-Infections

vasoactive-intestinal-peptide has been researched along with Paramyxoviridae-Infections* in 1 studies

Other Studies

1 other study(ies) available for vasoactive-intestinal-peptide and Paramyxoviridae-Infections

ArticleYear
Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung.
    European journal of pharmacology, 1983, Mar-25, Volume: 88, Issue:2-3

    Vasoactive intestinal peptide (VIP) was found to inhibit ovalbumin-induced histamine release from guinea-pig minced lung. Maximum inhibition occurred with a 10-20 min time of preincubation with VIP. Spontaneous histamine release was not altered by VIP. With 2 x 10(-6) M VIP, the dose-response curve to ovalbumin was shifted about 3-fold to the right, but the maximum histamine release was unaltered. Respiratory tract infection with parainfluenza 3 virus did not influence the inhibitory effect of VIP on histamine release.

    Topics: Animals; Antigens; Female; Gastrointestinal Hormones; Guinea Pigs; Histamine Release; Lung; Ovalbumin; Parainfluenza Virus 3, Human; Paramyxoviridae Infections; Time Factors; Vasoactive Intestinal Peptide

1983